• MJHLS Brand Logo

© 2020 MJH Life Sciences™ and Cure Today. All rights reserved.

Breast Cancer | Tumor

Black Women with Breast Cancer Experience More Treatment Delays, Prolonged Treatment Duration Compared With White Women

November 30th 2020, 10:00pm

Article

Several factors may lead to prolonged treatment duration for breast cancer including socioeconomic status, race, and barriers to care.

Oncology Nurses Provide A Compassionate and Encouraging Presence for Patients with Cancer

November 30th 2020, 2:00pm

Article

A patient with cancer discusses how the compassionate and encouraging presence of oncology nurses makes a difference in their cancer journey.

How Yoga Helped Me in My Post Breast Cancer Treatment Journey

November 28th 2020, 7:00pm

Article

A former oncologist discusses how yoga became a vital part of her recovery after a surprise breast cancer diagnosis.

By My Side As an Oncology Nurse — And a Friend

November 28th 2020, 3:00pm

Article

A cancer survivor describes how her oncology nurse was by her side through her cancer journey as both a nurse, and her friend.

Fertility Preservation Boosts Birth Rate After Breast Cancer Treatment

November 27th 2020, 7:00pm

Article

Women with breast cancer who undergo fertility preservation with breast cancer are more likely to give birth than those who do not, researchers report.

Keytruda With an Androgen Receptor Modulator May Produce a Modest Benefit in Women with Androgen Receptor-Positive, Triple-Negative Breast Cancer

November 25th 2020, 4:00pm

Article

Despite a modest benefit in these patients, principal investigator Dr. Yuan Yuan said she is looking “forward to the future” with regards to therapies that integrate nonsteroidal selective androgen receptor modulators for this patient population.

A Cancer Poem: Rock-Solid Strength

November 22nd 2020, 7:00pm

Article

A poem from a mother to her daughter after her breast cancer diagnosis.

FDA Grants Accelerated Approval to Keytruda-Chemotherapy Combination for TNBC

November 13th 2020, 8:00pm

Article

The Food and Drug Administration has approved the combination of Keytruda (pembrolizumab) with chemotherapy for patients with locally recurrent unresectable or metastatic triple-negative breast cancer who have a PD-L1 expression.

Love and Marriage: Tackling Two Bouts of Cancer Together

November 12th 2020, 4:00pm

Podcast

In this episode of the “CURE Talks Cancer” podcast, we spoke with a couple that has been married for 41 years about their journey as patient and caregiver during two bouts of triple-negative breast cancer. The couple, Janice and Rex Cowden, also give others facing similar situations advice on how to persevere together.

What Women Need to Know About a Breast Cancer Diagnosis During COVID-19

October 30th 2020, 6:00pm

Article

A breast surgical oncologist at The University of Texas MD Anderson Cancer Center notes that while breast cancer screening can be delayed a few months, it should not be skipped altogether.

x